Navigation Links
Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
Date:2/22/2011

JUPITER, Fla., Feb. 22, 2011 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries, announced today that it has launched FibreZyme® G200, a next generation, high performance enzyme designed to improve paper quality and improve the economics of various pulp and paper manufacturing processes.

Brian Murdoch, Dyadic's Senior Director Sales & Technical Development stated, "FibreZyme® G200 is a great addition to our product portfolio and provides further evidence of the value-adding capabilities of Dyadic's C1 platform technology. FibreZyme® G200 operates under wide pH and temperature ranges allowing for seamless integration into most pulp and paper manufacturing processes."

Specific attributes of FibreZyme® G200 include the following:

  • Reduces fiber raw material costs and petroleum-derived chemical usages
  • Reduces pulp refining energy requirements
  • Increases paper machine production rates and efficiencies
  • Improves softness in tissue production
  • Enhances pulp drainage rates and reduces paper drying demand
  • Enhances and restores fiber strength and increases inter-fiber bonding through fibrillation

New Production Platform

FibreZyme® G200 is produced using a new variant of Dyadic's patented and proprietary C1 platform technology which Dyadic refers to as the "white strain." Developed through sustained research efforts at Dyadic Netherlands, the white strain produces significantly less background proteins. These changes allow for more efficient and economical industrial scale production of highly targeted enzymes and proteins at greater purity levels.

Richard Jundzil, Dyadic's Vice President Operations stated, "FibreZyme® G200 represents the first product commercialized using the new C1 white strain. We now have in place all the molecular tools, scale-up experience and production processes necessary to support additional timely market introductions of new enzymes identified from the C1 and other genomes. Dyadic intends to utilize the white strain production platform to create a sustainable and more diverse product portfolio. We also intend to express new enzyme and protein targets with our collaborative partners in a variety of industries."

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, industrial enzyme and biopharmaceutical industries.  Please visit Dyadic's website at www.dyadic.com and Dyadic Netherland's website at www.dyadic.nl.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

For more information about FibreZyme® G200, please visit www.FibreZyme.com.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International Reports 2010 Third Quarter Financial Results
2. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
3. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
4. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
5. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
6. Dyadic International Engages The Abraham Group as Strategic Advisor
7. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
8. Dyadic International Strengthens Management Team
9. Dyadic International Extends Collaboration With The Scripps Research Institute
10. International team of scientists says its high NOON for microwave photons
11. Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board meeting in North ... in Harvard University’s Departments of Physics and Astronomy, has been selected for membership in ... winning team for the 2015 Breakthrough Prize in Fundamental physics for the discovery of ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which ... video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C kit. ... to perform Hi-C metagenome deconvolution using their own facilities, supplementing the company’s ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture Network (HTVN) ... their fourth annual Conference where founders, investors, innovative practitioners and collaborators are invited ... competition showcasing early stage digital health and med tech companies. , This day-long ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):